Latanoprost Teva (Latanoprost)

Latanoprost is a prostaglandin F2α analogue that activates FP receptors in the ciliary body. This activation increases uveoscleral outflow of aqueous humor, allowing fluid to drain more efficiently and thereby decreasing intra‑ocular pressure.

The dosing regimen for Latanoprost is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact schedule should follow the prescriber’s instructions.

Safety data for Latanoprost during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under medical supervision.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blockers such as timolol, prostaglandin analogues often have a more convenient dosing schedule and a different side‑effect profile, though individual response varies.

Store Latanoprost eye drops at room temperature, below 25 °C, in the original container. Protect the bottle from light and moisture, and keep the cap tightly closed when not in use to maintain product stability.

Latanoprost is applied as a single drop into the conjunctival sac of the affected eye(s) in the evening. The patient should wash hands, avoid touching the tip of the bottle to the eye or any surface, and gently close the eye for a few minutes after instillation.

Serious adverse events include severe ocular inflammation (such as uveitis or iritis), paradoxical increase in intra‑ocular pressure, corneal edema, and allergic reactions that may cause swelling or rash. Any sudden vision changes or intense eye pain should prompt immediate medical evaluation.

Latanoprost is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. It should also be avoided in individuals with active ocular infections, recent ocular surgery, or those who are unable to tolerate prostaglandin analogues.